ACON — Aclarion Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- $2.41m
- $2.52m
- $0.08m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0.049 | 0.06 | 0.06 | 0.075 |
Cost of Revenue | ||||
Gross Profit | -0.018 | -0.009 | -0.005 | -0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 4.53 | 2.64 | 5.62 | 4.95 |
Operating Profit | -4.48 | -2.58 | -5.56 | -4.88 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -4.64 | -4.95 | -7.07 | -4.91 |
Provision for Income Taxes | ||||
Net Income After Taxes | -4.64 | -4.95 | -7.07 | -4.91 |
Net Income Before Extraordinary Items | ||||
Net Income | -4.64 | -4.95 | -7.07 | -4.91 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | -5.49 | -5.96 | -7.48 | -4.91 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -11.2 | -12.9 | -19.6 | -8.82 |
Dividends per Share |